Vertex Pharmaceuticals Incorporated Shs Cert Deposito Arg Repr 0.00990099 ShsVertex Pharmaceuticals Incorporated Shs Cert Deposito Arg Repr 0.00990099 ShsVertex Pharmaceuticals Incorporated Shs Cert Deposito Arg Repr 0.00990099 Shs

Vertex Pharmaceuticals Incorporated Shs Cert Deposito Arg Repr 0.00990099 Shs

No trades
See on Supercharts
Market capitalization
‪100.25 B‬USD
1,227.130USD
‪−475.72 M‬USD
‪9.76 B‬USD
Beta (1Y)
−0.06

About Vertex Pharmaceuticals Incorporated


CEO
Reshma Kewalramani
Website
Headquarters
Boston
Founded
1989
ISIN
AR0468655268
FIGI
BBG01V2GH290
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Check out other big names from the same industry as VRTXD.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next: